Updates from the COVID-19 Pharmacoepidemiological Battlefield: Recent Victories and Battles Ahead [Plenary]

Saturday, August 27, 2022

10:00 AM – 11:30 AM CEST

Location: Congress Hall D4

Publication Number: 150

In this session, our four esteemed speakers will both look back over the many contributions from the pharmacoepidemiological society to the handling of the COVID-19 pandemic, as well as outline both learnings and likely challenges that lies ahead. Specifically, we will discuss the value of coordinated global collaborations in addressing urgent safety issues, what methodological insights we should take from these recent years, what regulators have learned and will expect from the pharmacoepidemiological society in the future, and what areas of the pandemic that will likely provide the study questions of the future.

Lead Speaker(s)

Anton Pottegård, PhD, MSc

University of Southern Denmark
Odense C, Denmark

Slides

Speaker(s)

Daniel Prieto-Alhambra, MD, MSc, PhD, FISPE

Professor of Pharmaco- and Device Epidemiology
CSM, NDORMS, University of Oxford
University of Oxford
Oxford, United Kingdom

Slides
J. Bradley Layton, PhD, FISPE

Director, Epidemiology
RTI Health Solutions
Research Triangle Park, North Carolina, United States

Slides
Miriam C. Sturkenboom, PharmD, PhD, FISPE

prof. dr.
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands

Slides
Catherine Cohet, PhD

Pharmacoepidemiology/RWE Senior Specialist
European Medicines Agency
Amsterdam, Noord-Holland, Netherlands

Slides